Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D CAPPON

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Drug and Chemical Toxicology|October 16, 2002
Effects of HCFC-123 exposure to maternal and infant rhesus monkeys on hepatic biochemistry, lactational parameters and postnatal growthG D Cappon, D A Keller, W J Brock, et al.
Toxicologic Pathology|May 5, 2011
Histologic and cytologic detection of endocrine and reproductive tract effects of exemestane in female rats treated for up to twenty-eight daysMichael L Mirsky, Lakshmi Sivaraman, Christopher Houle, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 17, 2011
Impaired reproduction in adult male, but not female, rats following juvenile treatment with the aromatase inhibitor, exemestaneGregg D Cappon, Robert E Chapin, Mark E Hurtt, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 13, 2012
Developmental toxicity of lersivirine in rabbits when administered throughout organogenesis and when limited to sensitive windows of axial skeletal developmentSarah N Campion, Christopher J Bowman, Gregg D Cappon, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 16, 2020
Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluationsNatasha R Catlin, Christine Stethem, Christopher J Bowman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 14, 2015
Age-related testicular toxicity of mGluR5 negative allosteric modulators appears to be unrelated to testis drug transporter maturitySarah N Campion, John M Marcek, Steven W Kumpf, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 25, 2013
Sensitivity of male reproductive endpoints in nonhuman primate toxicity studies: a statistical power analysisG D Cappon, D Potter, M E Hurtt, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Decreased maternal and fetal cholesterol following maternal bococizumab (anti-PCSK9 monoclonal antibody) administration does not affect rat embryo-fetal developmentSarah N Campion, Bora Han, Gregg D Cappon, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Nonclinical Safety Considerations for the Development of Pediatric-First Drugs: An Industry ViewG Schmitt, J Ridings, L De Schaepdrijver, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 12, 2020
Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluationsNatasha R Catlin, Christine M Stethem, Christopher J Bowman, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Drug and Chemical Toxicology|October 16, 2002
Effects of HCFC-123 exposure to maternal and infant rhesus monkeys on hepatic biochemistry, lactational parameters and postnatal growthG D Cappon, D A Keller, W J Brock, et al.
Toxicologic Pathology|May 5, 2011
Histologic and cytologic detection of endocrine and reproductive tract effects of exemestane in female rats treated for up to twenty-eight daysMichael L Mirsky, Lakshmi Sivaraman, Christopher Houle, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 17, 2011
Impaired reproduction in adult male, but not female, rats following juvenile treatment with the aromatase inhibitor, exemestaneGregg D Cappon, Robert E Chapin, Mark E Hurtt, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 13, 2012
Developmental toxicity of lersivirine in rabbits when administered throughout organogenesis and when limited to sensitive windows of axial skeletal developmentSarah N Campion, Christopher J Bowman, Gregg D Cappon, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 16, 2020
Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluationsNatasha R Catlin, Christine Stethem, Christopher J Bowman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 14, 2015
Age-related testicular toxicity of mGluR5 negative allosteric modulators appears to be unrelated to testis drug transporter maturitySarah N Campion, John M Marcek, Steven W Kumpf, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 25, 2013
Sensitivity of male reproductive endpoints in nonhuman primate toxicity studies: a statistical power analysisG D Cappon, D Potter, M E Hurtt, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Decreased maternal and fetal cholesterol following maternal bococizumab (anti-PCSK9 monoclonal antibody) administration does not affect rat embryo-fetal developmentSarah N Campion, Bora Han, Gregg D Cappon, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Nonclinical Safety Considerations for the Development of Pediatric-First Drugs: An Industry ViewG Schmitt, J Ridings, L De Schaepdrijver, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 12, 2020
Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluationsNatasha R Catlin, Christine M Stethem, Christopher J Bowman, et al.
Pageof 7